Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22Leukemia 18Lymphoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Lymphoma, Non-Hodgkin 6Hodgkin Disease 6Graft vs Host Disease 6Myelodysplastic Syndromes 5Leukemia, Myeloid, Acute 5Lymphoma, Mantle-Cell 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Waldenstrom Macroglobulinemia 3Multiple Myeloma 3Hematologic Neoplasms 3Carcinoma, Renal Cell 3Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Mycosis Fungoides 2Lymphoma, T-Cell, Peripheral 2Lymphoma, B-Cell 2Leukemia, Myelomonocytic, Chronic 2Kidney Neoplasms 2Bronchiolitis Obliterans Syndrome 2Blast Crisis 2Thrombocythemia, Essential 1Stomach Neoplasms 1Sezary Syndrome 1

Interventions

Cyclophosphamide 18ofatumumab 14fludarabine 12Rituximab 11ibrutinib 10fludarabine phosphate 9acalabrutinib 7obinutuzumab 6Lenalidomide 6Bendamustine Hydrochloride 6venetoclax 5pirtobrutinib 4Vincristine 4Mesna 4Melphalan 4Immunotherapy, Adoptive 4Whole-Body Irradiation 3Mycophenolic Acid 3Chlorambucil 3Bortezomib 3Alemtuzumab 3spebrutinib 2navitoclax 2idelalisib 2Tacrolimus 2Tablets 2Stem Cell Transplantation 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2KW-2478 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, B-Cell × Pentostatin × Clear all
NCT00201721 2017-02-08

Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
28 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡